← Back to headlines
Mirum Targets $680M-$700M 2026 Sales, PSC NDA Shifts
Mirum Pharmaceuticals is targeting $680 million to $700 million in sales for 2026, as its PSC NDA submission has been shifted to the first half of next year.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
